Table 1.
Sample size for procedures before, during and after the 2nd dose campaign.
| Participant type | Number of compounds | Phase | Total FGDs |
|---|---|---|---|
| Laypersons | |||
| Not vaccinated (0 doses of OCV) | |||
| Men | 3 | Before & during/after | 6 |
| Women | 3 | Before & during/after | 6 |
| 1 dose of OCV | |||
| Men | 3 | Before & during/after | 6 |
| Women | 3 | Before & during/after | 6 |
| 2 dose of OCV | |||
| Men | 3 | During/after only | 3 |
| Women | 3 | During/after only | 3 |
| Total laypersons | 30 | ||
| Community-based health actors | |||
| Lay healthcare workers/community assistants | 3 | Before & during/after | 6 |
| Neighbourhood health committees | 3 | Before & during/after | 6 |
| Vaccinators | 3 | Before & during/after | 6 |
| Total health actors | 18 | ||